Zim Laboratories Ltd — Quarterly Results & Earnings

₹60.26

-0.45%

Profit Growth YoY-117.65%Latest quarter

Sales Growth YoY-3.72%Latest quarter

Sales CAGR 5Y6.42%5 year compound

Profit CAGR 5Y29.75%5 year compound

📋

Quarterly Performance

YoY Profit Growth-117.65%

🔴 Significant decline

YoY Sales Growth-3.72%

⚠️ Mild contraction

OPM 5Y Average

Operating profit margin

12.20%

EPS Growth 5Y

29.63%

Interest Coverage

Higher = safer debt servicing

1.91

ROE

4.96%

ROCE

8.16%

💡

Growth Analysis

Zim Laboratories Ltd reported YoY profit growth of -117.65% and revenue growth of -3.72% in the latest quarter. Significant profit decline — requires close monitoring. Over 5 years, sales compounded at 6.42% and profits at 29.75% annually. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.

More on Zim Laboratories Ltd

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Pharmaceuticals Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.